BLACKTHORN’S BTRX-246040 NOCICEPTIN PROGRAM IS FIRST MOLECULE AND CLINICAL PROGRAM TO INCORPORATE MINDSTRONG HEALTH’S PATENTED TECHNOLOGY...

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Sienna Biopharmaceuticals, Inc., a privately held, clinical stage medical dermatology and...

Indigo™ Cotton demonstrated an average yield improvement of 11% in the target environment of West Texas Farmers experienced productivity...

-Former Biogen leader George Scangos will be CEO, with Vicki Sato as Chairman of the Board -Company to apply immune programming at...

Acquisition Adds Phase IIb Product, Clinical Candidates and Novel Discovery Platform to Sienna's Growing Pipeline WESTLAKE VILLAGE,...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BlackThorn Therapeutics, a clinical stage biopharmaceutical company discovering and...

BOSTON, MASS. — July 21, 2016 — Indigo, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announced...

STRONG INVESTOR DEMAND INCREASES TOTAL INVESTMENTS TO $46M Westlake Village, CA, July 12, 2016 – Sienna Biopharmaceuticals, Inc....

Ann Arbor, Michigan-based Millendo Therapeutics (formerly known as Atterocor Inc), a biopharmaceutical company focused on treating orphan...